Maple Grove, MN, United States of America

Ngoc N Lu

This inventor holds 1 USPTO granted patent. Top assignee: Medtronic, Inc.. Active years: 2015.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Ngoc N Lu in Injectable Ropinirole Compositions

Introduction

Ngoc N Lu is an accomplished inventor based in Maple Grove, MN (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of injectable compositions for therapeutic use.

Latest Patents

Ngoc N Lu holds a patent for "Injectable ropinirole compositions and methods for making and using same." This innovative patent describes compositions and methods that utilize an injectable form of ropinirole, which is effective for treating conditions such as Parkinson's disease. The composition is designed to have a pH ranging from about 3.0 to about 6.5 and contains less than 3% by weight of impurities. These compositions are suitable for administration via infusion pumps and can be produced in an oxygen-free environment to enhance stability.

Career Highlights

Ngoc N Lu is currently employed at Medtronic, Inc., where she continues to advance her research and development efforts. Her work focuses on improving the efficacy and safety of injectable medications, which can have a profound impact on patient care.

Collaborations

Throughout her career, Ngoc N Lu has collaborated with notable colleagues, including Michael C Schmitz and Roger E Harrington. These partnerships have contributed to the successful development of her innovative patent.

Conclusion

Ngoc N Lu's work in injectable ropinirole compositions exemplifies her dedication to improving therapeutic options for patients. Her contributions to the field of pharmaceuticals highlight the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…